School of Pharmacy

UCSF is the recipient of a US$1 million, 3-year grant from the Howard Hughes Medical Institute (HHMI) to create a new and radical PhD program to train systems biologists.

By genetically engineering microbes to act like biological camera film, UCSF School of Pharmacy assistant professor Christopher A. Voigt, PhD and doctoral students show the potential of the new field of synthetic biology to create useful tools for medicine and technology.

Leaders from 6 Vietnamese pharmacy schools joined with the University of California, San Francisco (UCSF) School of Pharmacy and UCSF Global Health Sciences, and the United States Pharmacopeia to sign a partnership agreement on November 12, 2005 in Ho Chi Minh City, Vietnam to expand the role of...

A research collaboration between the University of California (UC) and Peking University will integrate the biological data acquisition strengths of the former with the physical and theoretical strengths of the latter, a move which scientists anticipate will ultimately lead to more effective, safer...

Robert Langridge, PhD, professor emeritus of the School of Pharmacy, University of California, San Francisco, is highlighted as one of 35 innovators of our time by the editors of Smithsonian Magazine in its November 5, 2005 issue.

A unique course of study offered by UCSF's School of Pharmacy has led a strong student to realize his goal of doing research and helping patients overseas. It has helped him to win a prized Fulbright Fellowship to boot.

Dissolving thin strips containing over-the-counter medicines are now being used by consumers to treat their coughs and colds and runny noses.

A new benefit for prescription drugs will be offered through Medicare beginning January 1, 2006. Medicare recipients who are eligible for this benefit must evaluate their drug benefit options and enroll in a drug plan.

Attempts have failed by Health Management Organizations (HMOs) to cut drug costs by putting physicians at financial risk if their prescription costs exceed their medical group's drug budget.

The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July